JP2025521231A5 - - Google Patents

Info

Publication number
JP2025521231A5
JP2025521231A5 JP2024572421A JP2024572421A JP2025521231A5 JP 2025521231 A5 JP2025521231 A5 JP 2025521231A5 JP 2024572421 A JP2024572421 A JP 2024572421A JP 2024572421 A JP2024572421 A JP 2024572421A JP 2025521231 A5 JP2025521231 A5 JP 2025521231A5
Authority
JP
Japan
Prior art keywords
seq
sequence shown
amino acid
acid sequence
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024572421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025521231A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/098753 external-priority patent/WO2023236971A1/zh
Publication of JP2025521231A publication Critical patent/JP2025521231A/ja
Publication of JP2025521231A5 publication Critical patent/JP2025521231A5/ja
Pending legal-status Critical Current

Links

JP2024572421A 2022-06-08 2023-06-07 Cd73抗体カクテル療法 Pending JP2025521231A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210639331.4 2022-06-08
CN202210639331 2022-06-08
PCT/CN2023/098753 WO2023236971A1 (zh) 2022-06-08 2023-06-07 Cd73抗体鸡尾酒疗法

Publications (2)

Publication Number Publication Date
JP2025521231A JP2025521231A (ja) 2025-07-08
JP2025521231A5 true JP2025521231A5 (cg-RX-API-DMAC10.html) 2026-05-20

Family

ID=89117604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024572421A Pending JP2025521231A (ja) 2022-06-08 2023-06-07 Cd73抗体カクテル療法

Country Status (8)

Country Link
US (1) US20260217849A1 (cg-RX-API-DMAC10.html)
EP (1) EP4538289A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025521231A (cg-RX-API-DMAC10.html)
KR (1) KR20250023471A (cg-RX-API-DMAC10.html)
CN (1) CN119403832A (cg-RX-API-DMAC10.html)
CA (1) CA3258260A1 (cg-RX-API-DMAC10.html)
TW (1) TW202405018A (cg-RX-API-DMAC10.html)
WO (1) WO2023236971A1 (cg-RX-API-DMAC10.html)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US6420140B1 (en) 1996-10-11 2002-07-16 Abgenix, Inc. Production of multimeric protein by cell fusion method
US20060073141A1 (en) 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
WO2017118613A1 (en) * 2016-01-08 2017-07-13 Syddansk Universitet Bispecific antibodies targeting human cd73
AU2017228470A1 (en) * 2016-03-04 2018-08-30 Bristol-Myers Squibb Company Combination therapy with anti-CD73 antibodies
EP4058150A2 (en) * 2019-11-15 2022-09-21 Genzyme Corporation Biparatopic cd73 antibodies
JP2023546743A (ja) * 2020-10-23 2023-11-07 中山康方生物医▲藥▼有限公司 抗cd73抗体及びその使用
TWI900705B (zh) * 2020-12-11 2025-10-11 大陸商上海華奧泰生物藥業股份有限公司 Cd73的抗原結合蛋白及其應用
US20240067747A1 (en) * 2021-01-13 2024-02-29 Shanghai Huaota Biopharmaceutical Co., Ltd. Cd73-binding protein and use thereof

Similar Documents

Publication Publication Date Title
JP2024508762A5 (cg-RX-API-DMAC10.html)
JP2024506940A5 (cg-RX-API-DMAC10.html)
JP2022119854A5 (cg-RX-API-DMAC10.html)
JP2022532927A5 (cg-RX-API-DMAC10.html)
JP2020518599A5 (cg-RX-API-DMAC10.html)
JP2024160287A5 (cg-RX-API-DMAC10.html)
FI3408295T3 (fi) Bispesifisiä vasta-ainekonstrukteja käsittävä farmaseuttinen koostumus
JP2016534052A5 (cg-RX-API-DMAC10.html)
JP2010511665A5 (cg-RX-API-DMAC10.html)
JP2021524231A5 (cg-RX-API-DMAC10.html)
JP2022512704A5 (cg-RX-API-DMAC10.html)
JP2021521159A5 (cg-RX-API-DMAC10.html)
JP2021514670A5 (cg-RX-API-DMAC10.html)
AR124067A2 (es) Formulaciones estables que comprenden un anticuerpo biespecífico para egfr / c-met
JP2024544523A5 (cg-RX-API-DMAC10.html)
JP2024538140A5 (cg-RX-API-DMAC10.html)
JP2023540025A5 (cg-RX-API-DMAC10.html)
JP2023504748A5 (cg-RX-API-DMAC10.html)
CN113797333A (zh) 一种新型冠状病毒抗体的药物组合物及其用途
CN118105485B (zh) 一种稳定的抗人IL-4Rα单克隆抗体制剂
JP2024540377A5 (cg-RX-API-DMAC10.html)
US20250019421A1 (en) Pharmaceutical formulation comprising bispecific antibody against rabies virus g protein and preparation method therefor
JP2023502398A5 (cg-RX-API-DMAC10.html)
JP2022519796A5 (cg-RX-API-DMAC10.html)
JP2023507981A5 (cg-RX-API-DMAC10.html)